230 related articles for article (PubMed ID: 32886229)
1. Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence.
Martínez-Pérez Y; Nequiz-Avendaño M; García-Torres I; Gudiño-Zayas ME; López-Velázquez G; Enríquez-Flores S; Mendoza E; Saavedra E; Pérez-Tamayo R; León-Avila G; Olivos-García A
Parasitol Res; 2020 Oct; 119(10):3491-3502. PubMed ID: 32886229
[TBL] [Abstract][Full Text] [Related]
2. Entamoeba histolytica thioredoxin reductase: molecular and functional characterization of its atypical properties.
Arias DG; Regner EL; Iglesias AA; Guerrero SA
Biochim Biophys Acta; 2012 Dec; 1820(12):1859-66. PubMed ID: 22967759
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide against E. histolytica and their analysis as potential thioredoxin reductase inhibitors.
Soto-Sánchez J; Caro-Gómez LA; Paz-González AD; Marchat LA; Rivera G; Moo-Puc R; Arias DG; Ramírez-Moreno E
Parasitol Res; 2020 Feb; 119(2):695-711. PubMed ID: 31907668
[TBL] [Abstract][Full Text] [Related]
4. Virulence and virulence factors in Entamoeba histolytica, the agent of human amoebiasis.
Faust DM; Guillen N
Microbes Infect; 2012 Dec; 14(15):1428-41. PubMed ID: 22710276
[TBL] [Abstract][Full Text] [Related]
5. Metronidazole hydrazone conjugates: Design, synthesis, antiamoebic and molecular docking studies.
Ansari MF; Siddiqui SM; Agarwal SM; Vikramdeo KS; Mondal N; Azam A
Bioorg Med Chem Lett; 2015 Sep; 25(17):3545-9. PubMed ID: 26174554
[TBL] [Abstract][Full Text] [Related]
6. Regulation of virulence of Entamoeba histolytica.
Marie C; Petri WA
Annu Rev Microbiol; 2014; 68():493-520. PubMed ID: 25002094
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the redefinition of the agent of amoebiasis.
Lucas R; Upcroft JA
Rev Latinoam Microbiol; 2001; 43(4):183-7. PubMed ID: 17061507
[TBL] [Abstract][Full Text] [Related]
8. Entamoeba thiol-based redox metabolism: A potential target for drug development.
Jeelani G; Nozaki T
Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086
[TBL] [Abstract][Full Text] [Related]
9. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase.
Leitsch D; Kolarich D; Wilson IB; Altmann F; Duchêne M
PLoS Biol; 2007 Aug; 5(8):e211. PubMed ID: 17676992
[TBL] [Abstract][Full Text] [Related]
10. Cysteine proteinases and the pathogenesis of amebiasis.
Que X; Reed SL
Clin Microbiol Rev; 2000 Apr; 13(2):196-206. PubMed ID: 10755997
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-linked metabolism in Entamoeba histolytica.
Arias DG; Gutierrez CE; Iglesias AA; Guerrero SA
Free Radic Biol Med; 2007 May; 42(10):1496-505. PubMed ID: 17448896
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence.
Davis PH; Zhang X; Guo J; Townsend RR; Stanley SL
Mol Microbiol; 2006 Sep; 61(6):1523-32. PubMed ID: 16968225
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
Ximénez C; González E; Nieves M; Magaña U; Morán P; Gudiño-Zayas M; Partida O; Hernández E; Rojas-Velázquez L; García de León MC; Maldonado H
PLoS One; 2017; 12(8):e0181962. PubMed ID: 28771523
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of intracellular hypoxia and adequate heat shock response are essential requirements for pathogenicity and virulence of Entamoeba histolytica.
Santos F; Nequiz M; Hernández-Cuevas NA; Hernández K; Pineda E; Encalada R; Guillén N; Luis-García E; Saralegui A; Saavedra E; Pérez-Tamayo R; Olivos-García A
Cell Microbiol; 2015 Jul; 17(7):1037-51. PubMed ID: 25611463
[TBL] [Abstract][Full Text] [Related]
15. Energy production in Entamoeba histolytica: new perspectives in rational drug design.
Saavedra-Lira E; Pérez-Montfort R
Arch Med Res; 1996; 27(3):257-64. PubMed ID: 8854380
[TBL] [Abstract][Full Text] [Related]
16. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
Ravdin JI; Shain DC; Kelsall BL
Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
[TBL] [Abstract][Full Text] [Related]
18. Entamoeba histolytica: erythrophagocytosis, collagenolysis, and liver abscess production as virulence markers.
Tsutsumi V; Ramírez-Rosales A; Lanz-Mendoza H; Shibayama M; Chávez B; Rangel-López E; Martínez-Palomo A
Trans R Soc Trop Med Hyg; 1992; 86(2):170-2. PubMed ID: 1440779
[TBL] [Abstract][Full Text] [Related]
19. In vivo programmed cell death of Entamoeba histolytica trophozoites in a hamster model of amoebic liver abscess.
Villalba-Magdaleno JD; Pérez-Ishiwara G; Serrano-Luna J; Tsutsumi V; Shibayama M
Microbiology (Reading); 2011 May; 157(Pt 5):1489-1499. PubMed ID: 21349978
[TBL] [Abstract][Full Text] [Related]
20. Src and PI3 K inhibitors affect the virulence factors of Entamoeba histolytica.
López-Contreras L; Hernández-Ramírez VI; Flores-García Y; Chávez-Munguía B; Talamás-Rohana P
Parasitology; 2013 Feb; 140(2):202-9. PubMed ID: 23058125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
